Skip to main content

Radiation Dose Management Market Likely To Increase Size, Shares, And Demand Forecast 2022-2032

 Radiation dose is the amount of radiation absorbed by a patient during a diagnostic imaging procedure. A large dose of radiation can cause tissue damage and increase the risk of developing cancer in later stages of life.The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players.

The global radiation dose management market was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022–2032. The growth in the global radiation dose management market is expected to be driven by the rising prevalence of chronic disorders requiring diagnostic intervention, the growing focus on interventional radiology (IR), and the growing awareness surrounding patient safety and the harmful and biological effects of overexposure to ionizing radiation.

Impact of COVID-19

The decline in imaging volumes during the COVID-19 pandemic impacted the utilization of radiation diagnostic equipment. All radiology equipment had to be thoroughly disinfected using ethanol owing to the strict protocols to minimize the risk of transmission of COVID-19.

In the post-COVID-19 scenario, imaging volumes are expected to return gradually to pre-pandemic levels. As the severity of the COVID-19 pandemic declines, hospitals are expected to reallocate resources toward radiology and pursue diagnostic imaging with renewed vigor. Moreover, in the long term, radiology practices could be permanently redesigned as radiologists become more comfortable treating patients remotely. Furthermore, hospitals and other healthcare institutions are expected to be better equipped to deal with unprecedented events that may disrupt their businesses.

The COVID-19 pandemic placed high importance on automating tasks requiring manual intervention. While conventionally, data transfer and dose recording were done manually, the advent of advanced dose management software (DMS) has enabled automated data transfer from imaging systems into the DMS as well as automated dose recording. This helps eliminate human error and reduces the need for human intervention, which was a concept that gained momentum as a result of the COVID-19 pandemic.

Market Segmentation

Radiation Dose Management Market dynamic

Recent Developments in the Global Radiation Dose Management Market

• In December 2020, Bayer AG launched Radimetrics v3.0, the latest evolution of its enterprise dose management utility.
• In December 2020, FUJIFILM Holdings Corporation launched the unique SYNAPSE Dose 2.0 to provide a comprehensive system for managing patient radiation exposure across several imaging modalities.
• In January 2020, Agfa HealthCare collaborated with Maasstad Hospital in the Netherlands to support advancements in the consistency and optimization of radiation doses.
• In April 2019, Qaelum NV signed an agreement with TOYO Corporation to distribute its dose monitoring solution, DOSE, in Japan.
• In January 2019, SST Group, Inc. partnered with Intermountain Healthcare to implement a software platform for the Radiation Dose Monitor (RDM). The software platform permits medical professionals to manage, examine, and optimize the dose delivered to a patient during interventional procedures, medical imaging examinations, and image-guided surgery.
• In August 2018, Imalogix launched a newer version of its radiation dose management platform with additional fluoroscopy capabilities. The software solution can automatically calculate the peak skin dose for the patient during a fluoroscopic procedure.
• In August 2018, Guerbet LLC USA, a subsidiary of the Guerbet Group, partnered with Imalogix to decrease inconsistency and advance the quality, safety, and competence of care around radiation dose management, to enable the network health system and member facilities to monitor patient radiation dose on a per-procedure and cumulative basis.
• In March 2018, PACSHealth, LLC launched DoseMonitor, a radiation dose management software for tracking radiation dose absorption.

Demand — Drivers and Limitations

Following are the drivers for the global radiation dose management market:

• Increasing installed bases of radiology equipment and the number of scans lead to a higher risk of radiation exposure, thus creating demand for dose management solutions.
• The increasing prevalence of cardiovascular diseases and growing occupational hazards in cath labs lead to the growing concern surrounding the effects of radiation exposure.
• Growing focus on interventional radiology (IR) is expected to increase demand for IR imaging systems and subsequently lead to a higher risk of radiation exposure.
• Increasing concern related to radiation overexposure is leading to higher adoption of dose management solutions.
• Growing awareness and initiatives for radiation dose management are expected to push the adoption of dose management software.
• Advancements in dose optimization and benchmarking in various countries will encourage healthcare institutions to adopt dose management software.

The market is expected to face some limitations as well due to the following challenges:

• The lack of awareness among the population and the shortage of skilled and trained professionals leading to a steep learning curve hinders the adoption of dose management software.
• The lack of diagnostic reference levels (DRLs) for radiation dose benchmarking in low-income countries causes healthcare institutions to not pursue the adoption of dose management software with vigor.

Check out the detailed table of content here: — https://bisresearch.com/requestsample?id=1409type=toc

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

• Agfa-Gevaert Group
• Bracco
• Bayer AG
• Canon Inc.
• FUJIFILM Holdings Corporation
• Guerbet
• General Electric Company
• Imalogix
• Infinitt Healthcare Co., Ltd.
• Koninklijke Philips N.V.
• LANDAUER
• Medic Vision Imaging Solutions Ltd.
• Medsquare
• MyXrayDose Ltd.
• Novarad Corporation
• PACSHealth, LLC
• Qaelum NV
• Sectra AB
• SST Group Inc.
• Siemens Healthineers AG
• Virtual Phantoms Inc.

Companies that are not a part of the previously mentioned pool have been well represented across different sections of the report (wherever applicable).

Get Free Sample Report — https://bisresearch.com/requestsample?id=1409type=download

The following can be considered USPs of this report:

· Detailed impact of COVID-19 on the global radiation dose management market

· Gap analysis

· Price analysis

· Detailed segmentation based on product with in-depth information on each of the 15 dose management software

· Market share analysis of the major players done to offer a holistic view of the global radiation dose management market landscape

The companies manufacturing and commercializing radiation dose management software for use in hospitals, diagnostic centers, research institutes, and ambulatory and specialty clinics should buy this report. Moreover, companies who are into dosimetry systems and looking to venture into software solutions for radiation dose management can also buy this report

Comments

Popular posts from this blog

Pharmacogenomics Services Market Dynamics, Competitive Landscape & Forecast to 2031

  BIS healthcare experts have found the pharmacogenomics services industry to be one of the most rapidly evolving and dynamic markets. The global  pharmacogenomics services market  is projected to reach $9,346.8 million by 2031 from $5,060.0 million in 2020, at a CAGR of 5.71% during the forecast period 2021-2031. The market is driven by certain factors, including increasing prevalence of infectious diseases and various types of cancer, increasing adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogenomics for drug discovery and development. Currently, the pharmacogenomics services industry is witnessing an upsurge due to the increasing prevalence of infectious diseases and various types of cancer, increase in adoption of personalized medicine shifting the paradigm from reaction to prevention, increasing rate of adverse drug reaction, and surge in usage of pharmacogen...

Oncolytic Virus Therapies Market is projected to grow at a whopping CAGR of 26.28% over the period 2020-2030

  The global oncolytic virus therapies market is undergoing a significant flux with regard to the advancements that have already taken place and are currently invading the market space. Additionally, with the emergence of virus therapeutics, there is an immense potential for these emerging sub-markets to continue fueling the overall oncolytic virus therapies market. This chapter reviews the significant drivers and restraints that are considerably impacting the dynamicity of the global oncolytic virus therapies market. Due to the ever-rising incidence of cancers, the need for better products and services is becoming more evident. Several key players are aligning their technologies as per the market requirements to provide technologically advanced products and services by adopting inorganic strategies such as agreements, partnerships, and collaborations. The global oncolytic virus therapies market is projected to grow at a whopping CAGR of 26.28% over the period 2020-2030 and reach ...

PP Compound Market for Automotive Industry Open Up New Revenue Opportunities

  The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts. Impact of COVID-19 on the Global Polypropylene (PP) Compound Market for Automotive Industry Due to the COVID–19 pandemic, the PP compound market was severely impacted like many other industries. Automotive production in 2020 saw a decline of almost 16% due to the impact of COVID-19. In order to control the spread of the virus, the majority of the countries around the globe imposed stay-at-home orders, which led to the shutting of many manufacturing plants. As the production of vehicles declined, the demand for PP compounds suffered negatively in the year 2020. Market Segmentation Global Polypropylene (PP) Compound Market for Automotive Industry by Applic...